Healthcare Analysts discuss the recently held ESMO 2025 (European Society for Medical Oncology) with Olema (OLMA) on an Analyst/Industry conference call to be held on October 23 at 12 pm. Webcast Link
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLMA:
- Olema Pharmaceuticals Reports Positive Phase 1b/2 Trial Results
- Midday Fly By: AWS hit by outage, Kering sells beauty unit
- Morning Movers: Cleveland-Cliffs surges following earnings report
- Promising Potential of Olema Pharmaceuticals’ Palazestrant in ER+/HER- Metastatic Breast Cancer Treatment: An Analyst’s Buy Recommendation
- Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’